Director, SEC Reporting & Technical Accounting

Who We Are Bolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISACs), a new class of immuno-oncology therapeutics. This is a unique opportunity to join and build, with like-minded colleagues, a company that will transform the lives of individuals with cancer.

Reporting to the Vice President, Principal Accounting Officer, this energetic, self-starter will serve as the Director of Technical Accounting to lead our SEC reporting and technical accounting, manage our internal controls and assist in the accounting operations around more complex areas such as R&D accruals, equity, and revenue.